Journal of Human Reproductive Science
Home Ahead of Print Current Issue Archives
   Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size    Users online: 600

   Table of Contents     
Year : 2011  |  Volume : 4  |  Issue : 1  |  Page : 43-48

Endometrial regeneration using autologous adult stem cells followed by conception by in vitro fertilization in a patient of severe Asherman's syndrome

1 Dr. Nagori's Institute for Infertility and IVF, Ahmedabad, India
2 Stem Cure (Centre for Reproductive Medicine and Stem Cell Therapy), Ahmedabad, India

Date of Submission14-Dec-2009
Date of Decision04-Sep-2010
Date of Acceptance22-Oct-2010
Date of Web Publication28-Jun-2011

Correspondence Address:
Sonal Y Panchal
Dr. Nagori's Institute for Infertility and IVF, 2nd Floor, Kedar, Opp. Petrol Pump, Nr. Parimal Garden, Ahmedabad - 380 006
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0974-1208.82360

Rights and Permissions



In a woman with severe Asherman's syndrome, curettage followed by placement of intrauterine contraceptive device (IUCD) (IUCD with cyclical hormonal therapy) was tried for 6 months, for development of the endometrium. When this failed, autologous stem cells were tried as an alternative therapy. From adult autologous stem cells isolated from patient's own bone marrow, endometrial angiogenic stem cells were separated using immunomagnetic isolation. These cells were placed in the endometrial cavity under ultrasound guidance after curettage. Patient was then given cyclical hormonal therapy. Endometrium was assessed intermittently on ultrasound. On development of endometrium with a thickness of 8 mm and good vascularity, in vitro fertilization and embryo transfer was done. This resulted in positive biochemical pregnancy followed by confirmation of gestational sac, yolk sac, and embryonic pole with cardiac activity on ultrasound. Endometrial angiogenic stem cells isolated from autologous adult stem cells could regenerate injured endometrium not responding to conventional treatment for Asherman's syndrome.

Keywords: Adult stem cells, Asherman′s syndrome, endometrial regeneration, endometrial thickness, hormone replacement therapy

How to cite this article:
Nagori CB, Panchal SY, Patel H. Endometrial regeneration using autologous adult stem cells followed by conception by in vitro fertilization in a patient of severe Asherman's syndrome. J Hum Reprod Sci 2011;4:43-8

How to cite this URL:
Nagori CB, Panchal SY, Patel H. Endometrial regeneration using autologous adult stem cells followed by conception by in vitro fertilization in a patient of severe Asherman's syndrome. J Hum Reprod Sci [serial online] 2011 [cited 2023 Mar 27];4:43-8. Available from:

   Introduction Top

In this case report, we describe a case of Asherman's syndrome treated with adult autologous stem cells for endometrial regeneration that resulted in conception after in vitro fertilization-embryo transfer (IVF-ET).

The basis of this case is that endometrium is a dynamic, cyclically regenerating tissue, a unique model of physiological angiogenesis in adults. Angiogenesis results either from sprouting of new vessels through recruitment of local endothelial cells from neighbouring blood vessels and/or by endothelial progenitor cells circulating in the peripheral blood after release from the bone marrow. [1],[2],[3],[4] Bone marrow stem cells also contribute to regeneration of the endometrium. [5] On the basis of these facts, adult autologous bone marrow stem cells were used for regeneration of damaged endometrium.

   Case Report Top

A 33-year-old woman visited our clinic in November 2006. She was married for 8 years and had primary infertility. Her history, menstrual history and family history, was not significant. She had normal hormonal profile and husband's semen analysis was also normal. Her past treatment included a dilatation and curettage (D and C) in February 2005. This was followed by three cycles of superovulation with intrauterine insemination without success. She underwent IVF in June 2006, but did not conceive.

She presented to us with infertility and scanty menstruation since her D and C. Her first transvaginal ultrasound scan on day 3 of the menstrual cycle revealed normal size retroverted uterus with homogenous myometrium and thin single line endometrium, but intact endometriomyometrial junction. The left ovary measured 2.52 × 2.51 × 3.04 cm, had two antral follicles and a hemorrhagic cyst, and was adherent to uterus posteriorly. Right ovary measured 2.55 × 1.22 × 1.84 cm and had only one antral follicle. Doppler studies showed very poorly vascularised ovaries, even with minimum wall filter, pulse repetition frequency of 0.3, and gains -0.8.

A repeat scan on day 14 revealed that hemorrhagic cyst in left ovary had regressed partially. Right ovary showed a follicle of 20 mm which on color Doppler showed vascularity covering more than three-fourth of the follicular circumference with resistance index (RI) of 0.47 and peak systolic velocity (PSV) of 11.23 cm/s, but the endometrium was only 3.2 mm with branches of spiral vessels seen only up to endometrio-myometrial junction. The right uterine artery pulsatility index was 2.76.

Follow-up scan after three days still showed the same endometrial picture though follicle had ruptured. Midluteal ultrasound scan (ninth day post ovulation) showed that endometrium had failed to grow even during secretory phase, despite corpus luteum with vascular ring covering more than half of the corpus luteal circumference with RI of 0.43 and PSV of 10.43 cm/s on right side. Hysteroscopy was done in the next cycle to exclude endometrial adhesions. At hysteroscopy, severe endometrial adhesions were seen, which were cut [Figure 1] and [Figure 2].
Figure 1: Hysteroscopic picture - Endometrial adhesions

Click here to view
Figure 2: Postadhesiolysis hysteroscopic picture

Click here to view

IUCD-Cu T was placed to maintain surgically established patency of the endometrial cavity. Laparoscopy done showed bilateral cornual tubal block.

She was treated with cyclical estrogen and progesterones with ethinyloestradiol 0.05 mg from fifth to 25 th day of the cycle and with medroxy progesterone acetate 10 mg from 20 th to 25 th day for 6 months to obtain a functional endometrium. During this period, she had withdrawal bleeding, which was scanty. After 6 months, the IUCD was removed.

Ultrasound assessment of the endometrium in the following cycle showed no growth of the endometrium in the periovulatory and secretory phase of the menstrual cycle despite normal follicular development, rupture, and corpus luteum formation. The endometrium was perpetually 3.2 mm in thickness and echogenic [Figure 3].
Figure 3: Thin endometrium after removal of IUCD in preovulatory period

Click here to view

Due to poor endometrial development, she was advised surrogacy with IVF. Her FSH on Day 3 of cycle was 19.70 IU/ml with an antral follicle count of 2. In view of poor ovarian reserve, she was advised surrogacy with oocyte donation. The patient was ready for oocyte donation, but not for surrogacy. She was given oral oestradiol valerate tablets in increasing doses from 4 mg daily for 3 days, followed by 6 mg daily for another 3 days, and then 8 mg daily for a total of 25 days along with aspirin 75 mg daily for endometrial preparation. Ultrasound scans were done intermittently to assess the endometrium, but it never reached a thickness more than 3.6 mm. This hormone replacement therapy cycle was repeated for 6 months without improvement of the endometrium.

Based on reports of adult autologous stem cells applications for regeneration of injured cartilage and cardiomyocytes in cardiac infarction, it was thought that use of stem cells for regeneration of endometrium was worth trying, especially because endometrium naturally has a regenerating capacity. If the basal layer of the endometrium is repaired and further stimulated, it should increase in thickness. This was the basis of this experimental therapy.

The procedure was explained to the patient and her husband in March 2009. Possibilties of failure and risks of the procedure were also explained.

On June 15, 2009, her bone marrow aspiration was done from the iliac crest under local anesthesia maintaining strict asepsis. Aspiration was done using bone marrow biopsy needle and 10 ml syringe prewashed with heparin. Total 45 ml of bone marrow was aspirated. Collection was done in CPDA (Citrate-phosphate dextrose anticoagulant) medium using 1 ml of medium for 7 ml of bone marrow. It was sent to a dedicated stem cell laboratory working as per clinical GMP/GTP standard and having a working area with laminar airflow to class 100.

Bone marrow was centrifuged using histopaque density gradient at 1000 rpm for 10 mins and 102 million mononuclear cells were separated. These cells were further treated by column separation technique and customized cocktail of CD9, CD90, and CD133 antibodies was used for immunomagnetic isolation of endometrial angiogenic stem cells. Markers used for endometrial angiogenic stem cells were CD9, CD44, and CD90. Gene expression study for CD9, CD44, and CD90 using RT-PCR technique was done for differentiated cells. Total 39 million marker-positive endometrial angiogenic cells were supplied in 0.7 ml of PBS (phosphate buffer saline) with 2% autologous (patient's own) heat-inactivated serum on the next day for transplant. [6],[7],[8],[9],[10],[11],[12],[13],[14],[15],[16]

Patient was called with partially filled bladder on June 16, 2009, second day of her menstrual cycle. Curettage was done under anesthesia. With patient in lithotomy position, Sim's speculum in place, anterior retractor was used to retract the anterior vaginal wall, and volsellum was used to hold the anterior lip of cervix. ET cannula (Frydman classic cather 4.5, Laboratorie C.C.D., France) attached with 1-ml syringe, filled with 0.7-ml stem cell suspension, was advanced through cervix upto the fundal end of the endometrium under transabdominal ultrasound guidance. When the tip of the catheter was 0.5 cm below the fundus, piston was slowly advanced to allow slow steady flow of cell suspension in the uterine cavity. After instilling 0.3 ml of stem cell suspension at the fundus, injection was continued when cannula was gradually withdrawn out, till the tip reached mid cavity of the uterus. It was further very gently and slowly withdrawn out of the internal os and then external os, maintaining continuous pressure on the piston to prevent any back flow. Speculum and volsellum were removed, and patient was shifted when she recovered from anesthesia. She was discharged after 2 hours.

She was given oestradiol valerate 6 mg daily, starting on the same day for 25 days. Aspirin 75 mg was started from the same day and was continued.

Ultrasound was done on 14 th day and 19 th day of the cycle, which showed endometrial thickness of 5.0 and 5.2 mm, respectively, and color Doppler showed spiral vessels reaching subendometrial zone. Medroxy progesterone acetate 10 mg was further given from 20 th to 25 th day. After withdrawal bleeding, cyclical estrogen and progesterone therapy was repeated for four cycles. Ultrasound scans done at midcycle showed improvement in endometrial thickness, morphology, and vascularity [Figure 4].
Figure 4: Well-developed endometrium with low-resistance vascularity reaching zone 4

Click here to view

On November 2, 2009, endometrial thickness at ultrasound was 6.9 mm, with vascularity reaching intraendometrial region. There were dominant follicles in either ovary, which excludes the possibility of any endogenous luteinizing hormone surge. On November 6, 2009, three 4-6 cell Grade I donor oocyte IVF embryos were transferred. At this time, her endometrium was multilayered, with thickness of 7.1 mm and intraendometrial vascularity. She was given progesterone vaginal gel (Crinone 8%, manufactured by Fleet Laboratories, UK, marketed by Merck Serono) twice a day after ET, as luteal support and ethinyl oestradiol was continued in a dose of 6 mg daily along with Aspirin 75 mg daily.

Her serum β-hCG on November 21, 2009 was 8 297.1 mIU/ml. Once β-hCG was positive, the dose of oestradiol valerate was increased to 8 mg daily. Progesterone vaginal gel 8% was continued twice a day along with aspirin 75 mg daily. A single gestational sac of 12 mm, yolk sac of 2.9 mm, embryonic pole of 2.4 mm, with M-mode showing embryonic heart rate of 112/mt were seen at ultrasound on November 30, 2009. Follow-up scan was done at 8 weeks of pregnancy which showed a healthy fetus [Figure 5],[Figure 6],[Figure 7].
Figure 5: Gestational sac, yolk sac, and embryonic pole after embryo transfer and positive β-hCG test

Click here to view
Figure 6: M-mode of cardiac activity of embryo

Click here to view
Figure 7: 3D picture of 8 weeks scan

Click here to view

   Discussion Top

This was a case of infertility with severe Asherman's syndrome and bilateral cornual tubal block with low ovarian reserve. Anti-mullerian hormone, which is now considered to be the most reliable marker for ovarian reserve, was not routinely used at that time (2007) and was not easily available locally, and therefore was not done. Low ovarian reserve with blocked  Fallopian tube More Detailss had left her with an option of oocyte donation. This had to be delayed due to her poor endometrial thickness. Placement of IUCD after surgery and cyclical hormonal therapy in association with low-dose aspirin or nitroglycerine is an established protocol for development of functional endometrium. [17],[18] Placing IUCD after curettage, followed by cyclical oestrogen progesterone therapy with aspirin, could not improve her endometrium.

Stem cells derived from tissues such as bone marrow, cord blood, adipose tissue, or the amniotic fluid have demonstrated regenerative potential in a variety of diseases and degenerative disorders. [19]

Therefore, we tried to regenerate the endometrium with adult autologous stem cells after curettage, which was further supported with cyclical estrogen, progesterone, and aspirin for improving vascularization.

Bone marrow aspiration is fairly safe procedure with the risk of bleeding or infection, which are extremely rare when done meticulously in the hands of the expert.

Currettage was done to evoke injury-induced inflammatory reaction and hyperemia as homing induction, which in turn would enhance the response of endometrium to cyclical hormones.

We would like to qoute a study that has shown regeneration of injured endometrium using adult bone marrow cells.

'Donor-derived bone marrow cells have been identified in human uterine endometrium.' Recent evidence has implicated bone marrow-derived cells as possible endometrial progenitors. It is unknown whether these cells originate from bone marrow mesenchymal stem cells or, alternatively, are circulating endometrial cells originally derived from the endometrium and harbored in bone marrow. These cells, regardless of their origin, may serve as a source of reparative cells for the reproductive tract. Both stromal and epithelial cells were derived from bone marrow origin. These data show the potential for stem cells to have a role in the regeneration or repair of this tissue after injury. [20] Significant engraftment of endometrium by bone marrow is likely to occur after endometrial injury or inflammatory insult.

Additionally, the proliferation and development of endometrium are entirely regulated by hormonal stimuli. Ovarian estrogen and progesterone drive endometrial growth and apoptosis. [21],[22]

In the case described in this study, cyclical hormonal therapy resulted in development of endometrium with good vascularity after four cycles.

We tried to regenerate the endometrium by endometrial angiogenic stem cells isolated from autologous adult stem cells and transplanting them in the endometrium immediately after curettage. This was based on a study that describes that mononuclear cells collected from the menstrual blood contains a subpopulation of adherent cells and retains expression of the markers CD9, CD29, CD41a, CD44, CD59, CD73, CD90, and CD105; the markers used were CD9, CD44, and CD90 to isolate the desired cells. [19]

There is a minimal risk of developed cells presenting certain other markers during the process, but immunomagnetic isolation with specific marker antibodies reduces this possibility.

This experimental therapy may be tried on larger scale when the basal layer of endometrium is also damaged by surgical insult. The risk for malignancies after the use of adult autologous stem cells may be a concern in view of several reports, but we would like to draw attention to the fact that most of these reports discuss the cases where adult autologous stem cells were used to treat malignancies. Larger studies can completely exclude this risk.

The total cost of the therapy in an Indian set up comes to approximately Rs. 50 000 (Rupees fifty thousand), excluding the expense of IVF-ET. The cost is significantly lower than that to be spent for a surrogate mother. Moreover, it has an emotional and social advantage that the patient can bear her own child as against surrogacy.

To the best of our knowledge, no case of Asherman's syndrome conceived after endometrial regeneration with adult autologous stem cells after failure of all other conventional modes of treatment has been reported in literature. This therapy can be used as an alternative to surrogacy in females with severe Asherman's syndrome, though larger trials may be needed to establish this as proved line of treatment.

   References Top

1.Tepper OM, Sealove BA, Murayama T, Asahara T. Newly emerging concepts in blood vessel growth: Recent discovery of endothelial progenitor cells and their function in tissue regeneration. J Investig Med 2003;51:353-9.   Back to cited text no. 1
2.Jiang S, Walker L, Afentoulis M, Anderson DA, Jauron-Mills L, Corless CL, et al. Transplanted human bone marrow contributes to vascular endothelium. Proc Natl Acad Sci U S A 2004;101:16891-6.  Back to cited text no. 2
3.Urbich C, Dimmeler S. Endothelial progenitor cells: Characterization and role in vascular biology. Circ Res 2004;95:343-53.  Back to cited text no. 3
4.Peters BA, Diaz LA, Polyak K, Meszler L, Romans K, Guinan EC, et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 2005;11:261-2.  Back to cited text no. 4
5.Taylor HS. Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA 2004;292:81-5.  Back to cited text no. 5
6.Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-12.  Back to cited text no. 6
7.Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, et al. A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning. Blood 1997;90:5013-21.  Back to cited text no. 7
8.Piechaczek C. CD133. J Biol Regul Homeost Agents 2001;15:101-2.  Back to cited text no. 8
9.Bühring HJ, Seiffert M, Bock TA, Scheding S, Thiel A, Scheffold A, et al. Expression of novel surface antigens on early hematopoietic cells. Ann N Y Acad Sci 1999;872:25-38.  Back to cited text no. 9
10.Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M, Bhatia M. Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 2000;95:2813-20.  Back to cited text no. 10 Wynter EA, Buck D, Hart C, Heywood R, Coutinho LH, Clayton A, et al. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 1998;16:387-96.  Back to cited text no. 11
12.Gehling UM, Ergün S, Schumacher U, Wagener C, Pantel K, Otte M, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000;95:3106-12.  Back to cited text no. 12
13.Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952-8.  Back to cited text no. 13
14.Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 2000;97:14720-5.  Back to cited text no. 14
15.Cummings BJ, Uchida N, Tamaki SJ, Salazar DL, Hooshmand M, Summers R, et al. Human neural stem cells differentiate and promote locometer recovery in spinal cord-injured mice. Proc Natl Acad Sci U S A 2005;102:14069-74.  Back to cited text no. 15
16.Bussolati B, Bruno S, Grange C, Buttiglieri S, Deregibus MC, Cantino D, et al. Isolation of renal progenitor cells from adult human kidney. Am J Pathol 2005;166:545-55   Back to cited text no. 16
17.Yu DM, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome - one century later. Fertil Steril 2008;89:759-79.  Back to cited text no. 17
18.Valle RF, Scirra JJ. Intrauterine adhesions: Hysteroscopic diagnosis, classification, treatment and reproductive outcome. Am J Obstet Gynecol 1988;158:1459-70.  Back to cited text no. 18
19.Meng X, Ichim TE, Zhong J, Rogers A, Yin Z, Jackson J, et al. Endometrial regenerative cells: A novel stem cell population. J Transl Med 2007;5:57.  Back to cited text no. 19
20.Du H, Taylor HS. Contribution of bone marrow-derived stem cells to endometrium and endometriosis. Stem Cells 2007;25:2082-6.  Back to cited text no. 20
21.Narkar M, Kholkute S, Chitlange S, Nandedkar T. Expression of steroid hormone receptors, proliferation and apoptotic markers in primate endometrium. Mol Cell Endocrinol 2006;246:107-13.  Back to cited text no. 21
22.Song M, Ramaswamy S, Ramachandran S, Flowers LC, Horowitz IR, Rock JA, et al. Angiogenic role for glycodelin in tumorigenesis. Proc Natl Acad Sci U S A 2001;98:9265-70.  Back to cited text no. 22


  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7]

This article has been cited by
1 Autologous bone marrow-derived nucleated cell (aBMNC) transplantation improves endometrial function in patients with refractory Asherman’s syndrome or with thin and dysfunctional endometrium
Gurkan Arikan, Volkan Turan, Meryem Kurekeken, Hasan Sami Goksoy, Zeynep Dogusan
Journal of Assisted Reproduction and Genetics. 2023;
[Pubmed] | [DOI]
2 Hysteroscopic injections of autologous endometrial cells and platelet-rich plasma in patients with thin endometrium: a pilot randomized study
Zulfiia Efendieva, Polina Vishnyakova, Inna Apolikhina, Daria Artemova, Kirill Butov, Elena Kalinina, Tatiana Fedorova, Anna Tregubova, Aleksandra Asaturova, Timur Fatkhudinov, Gennady Sukhikh
Scientific Reports. 2023; 13(1)
[Pubmed] | [DOI]
3 Treatment options for endometrial hypoproliferation
Yigit Cakiroglu, Bulent Tiras, Jason Franasiak, Emre Seli
Current Opinion in Obstetrics & Gynecology. 2023; Publish Ah
[Pubmed] | [DOI]
4 Autologous Human Mesenchymal Stem Cell-Based Therapy in Infertility: New Strategies and Future Perspectives
Zahirrah Begam Mohamed Rasheed, Fazlina Nordin, Wan Safwani Wan Kamarul Zaman, Yuen-Fen Tan, Nor Haslinda Abd Aziz
Biology. 2023; 12(1): 108
[Pubmed] | [DOI]
5 The Role of Endometrial Stem/Progenitor Cells in Recurrent Reproductive Failure
Hannan Al-Lamee, Christopher J. Hill, Florence Turner, Thuan Phan, Andrew J. Drakeley, Dharani K. Hapangama, Nicola Tempest
Journal of Personalized Medicine. 2022; 12(5): 775
[Pubmed] | [DOI]
6 Peptidome analysis of human intrauterine adhesion tissues and the identification of antifibrotic peptide
Xiangdong Hua, Yan Zhang, Juan Xu, Lu Xu, Yaqian Shi, Dazhen Yang, Xiaoyan Gu, Sumin Wang, Xuemei Jia, Feng Xu, Jie Chen, Xiaoyan Ying
The Journal of Biomedical Research. 2022; 36(0): 1
[Pubmed] | [DOI]
7 circPTP4A2-miR-330-5p-PDK2 Signaling Facilitates In Vivo Survival of HuMSCs on SF-SIS Scaffolds and Improves the Repair of Damaged Endometrium
Yuanyuan Zheng, Linhao Li, Xuewei Bi, Ruyue Xue, Francesca Diomede
Oxidative Medicine and Cellular Longevity. 2022; 2022: 1
[Pubmed] | [DOI]
8 Treating intrauterine adhesion using conditionally reprogrammed physiological endometrial epithelial cells
Siyu Xia, Ming Wu, Xinhao Zhou, Xiu Zhang, Lina Ye, Kang Zhang, Yiyi Kang, Jun Liu, Yunci Zhang, Wang Wu, Dirong Dong, Hong Chen, Hui Li
Stem Cell Research & Therapy. 2022; 13(1)
[Pubmed] | [DOI]
9 Enhancing Stem Cell-Based Therapeutic Potential by Combining Various Bioengineering Technologies
In-Sun Hong
Frontiers in Cell and Developmental Biology. 2022; 10
[Pubmed] | [DOI]
10 Endometriosis-associated infertility: From pathophysiology to tailored treatment
Giulia Bonavina, Hugh S. Taylor
Frontiers in Endocrinology. 2022; 13
[Pubmed] | [DOI]
11 Clinical Evaluation of Autologous and Allogeneic Stem Cell Therapy for Intrauterine Adhesions: A Systematic Review and Meta-Analysis
Jia-ming Chen, Qiao-yi Huang, Wei-hong Chen, Shu Lin, Qi-yang Shi
Frontiers in Immunology. 2022; 13
[Pubmed] | [DOI]
12 Applications of Hydrogels in Premature Ovarian Failure and Intrauterine Adhesion
Donghai Zhang, Chuanfeng Ding, Tao Duan, Qian Zhou
Frontiers in Materials. 2022; 9
[Pubmed] | [DOI]
13 Research progress of stem cell therapy for endometrial injury
Juan Cen, Yichen Zhang, Yindu Bai, Shenqian Ma, Chuan Zhang, Lin Jin, Shaofeng Duan, Yanan Du, Yuqi Guo
Materials Today Bio. 2022; : 100389
[Pubmed] | [DOI]
14 Endometrial thickness: How thin is too thin?
Emily A. Jacobs, Brad Van Voorhis, Jennifer F. Kawwass, Laxmi A. Kondapalli, Kimberly Liu, Anuja Dokras
Fertility and Sterility. 2022; 118(2): 249
[Pubmed] | [DOI]
15 Is It Possible to Treat Infertility with Stem Cells?
P. Petric, E. Vrtacnik-Bokal, M. Stimpfel
Reproductive Sciences. 2021; 28(6): 1733
[Pubmed] | [DOI]
16 Endometrial membrane organoids from human embryonic stem cell combined with the 3D Matrigel for endometrium regeneration in asherman syndrome
Xiuxiu Jiang, Xingmiao Li, Xiangwei Fei, Jiajie Shen, Jianhua Chen, Meijun Guo, Yangyang Li
Bioactive Materials. 2021; 6(11): 3935
[Pubmed] | [DOI]
17 Uterine magnetic resonance image segmentation based on deep learning
Yu’ang Niu, Yuanyang Zhang, Liping Ying, Hong Li, Wenbo Chen, Hanci Miao, Nan Bao
Journal of Physics: Conference Series. 2021; 1861(1): 012067
[Pubmed] | [DOI]
18 3D stem cell-laden artificial endometrium: successful endometrial regeneration and pregnancy
Se-Ra Park, Soo-Rim Kim, Jae Been Im, Chan Hum Park, Hwa-Yong Lee, In-Sun Hong
Biofabrication. 2021; 13(4): 045012
[Pubmed] | [DOI]
19 Endometrial stem cells: origin, biological function, and therapeutic applications for reproductive disorders
Nafeesa Abuwala, Reshef Tal
Current Opinion in Obstetrics & Gynecology. 2021; 33(3): 232
[Pubmed] | [DOI]
20 Uterine Stem Cells and Benign Gynecological Disorders: Role in Pathobiology and Therapeutic Implications
Malak El Sabeh, Sadia Afrin, Bhuchitra Singh, Mariko Miyashita-Ishiwata, Mostafa Borahay
Stem Cell Reviews and Reports. 2021; 17(3): 803
[Pubmed] | [DOI]
21 Very small embryonic-like stem cells (VSELs) regenerate whereas mesenchymal stromal cells (MSCs) rejuvenate diseased reproductive tissues
Deepa Bhartiya, Pushpa Singh, Diksha Sharma, Ankita Kaushik
Stem Cell Reviews and Reports. 2021;
[Pubmed] | [DOI]
22 Strategies for managing Asherman's syndrome and endometrial atrophy: Since the classical experimental models to the new bioengineering approach
Lucía Miguel-Gómez, Mónica Romeu, Antonio Pellicer, Irene Cervelló
Molecular Reproduction and Development. 2021; 88(8): 527
[Pubmed] | [DOI]
23 Cell-based endometrial regeneration: current status and future perspectives
Neda Keyhanvar, Nosratollah Zarghami, Nathalie Bleisinger, Hamed Hajipour, Amir Fattahi, Mohammad Nouri, Ralf Dittrich
Cell and Tissue Research. 2021; 384(2): 241
[Pubmed] | [DOI]
24 Autologous platelet-rich plasma treatment for moderate-severe Asherman syndrome: the first experience
Lusine Aghajanova, Viji Sundaram, Chia-Ning Kao, Joseph M. Letourneau, Evelyna Manvelyan, Marcelle I. Cedars, Heather G. Huddleston
Journal of Assisted Reproduction and Genetics. 2021; 38(11): 2955
[Pubmed] | [DOI]
25 The Latest Developments in Immunomodulation of Mesenchymal Stem Cells in the Treatment of Intrauterine Adhesions, Both Allogeneic and Autologous
Jia-ming Chen, Qiao-yi Huang, Yun-xia Zhao, Wei-hong Chen, Shu Lin, Qi-yang Shi
Frontiers in Immunology. 2021; 12
[Pubmed] | [DOI]
26 A Simulation Study on the Growth of Oviduct Mucosa Cells in the Uterine Cavity Microenvironment
Cheng-Rong Wu, Hua-Lei Cai, Di-Xian Cai, Tao-Lan Li, Rong Shen, Dan Zi
International Journal of Women's Health. 2021; Volume 13: 829
[Pubmed] | [DOI]
27 Possibilities of using platelet-rich autoplasm in the complex treatment of patients with intrauterine synechiae
Sergey A. Martynov, Leyla V. Adamyan, Alek S. Arakelyan, Tatyana A. Fyodorova, Oksana A. Bystrykh
Gynecology. 2021; 23(3): 250
[Pubmed] | [DOI]
28 Recent trends in therapeutic strategies for repairing endometrial tissue in intrauterine adhesion
Junyan Ma, Hong Zhan, Wen Li, Liqi Zhang, Feng Yun, Ruijin Wu, Jun Lin, Yangyang Li
Biomaterials Research. 2021; 25(1)
[Pubmed] | [DOI]
29 Research Progress of Regenerative Medicine in the Treatments for Thin Endometrium
?? ?
Advances in Clinical Medicine. 2021; 11(02): 451
[Pubmed] | [DOI]
30 Unresponsive thin endometrium caused by Asherman syndrome treated with umbilical cord mesenchymal stem cells on collagen scaffolds: a pilot study
Yanling Zhang, Libing Shi, Xiaona Lin, Feng Zhou, Liaobing Xin, Wenzhi Xu, Huaying Yu, Jing Li, Mei Pan, Yibin Pan, Yongdong Dai, Yinli Zhang, Jia Shen, Lijuan Zhao, Min Lu, Songying Zhang
Stem Cell Research & Therapy. 2021; 12(1)
[Pubmed] | [DOI]
31 Stem cell-based therapy for ameliorating intrauterine adhesion and endometrium injury
Yu-Ting Song, Peng-Cheng Liu, Jie Tan, Chen-Yu Zou, Qian-Jin Li, Jesse Li-Ling, Hui-Qi Xie
Stem Cell Research & Therapy. 2021; 12(1)
[Pubmed] | [DOI]
32 Human Acellular Amniotic Matrix with Previously Seeded Umbilical Cord Mesenchymal Stem Cells Restores Endometrial Function in a Rat Model of Injury
Shan Wang, Cheng Shi, Xiaohui Cai, Yanbin Wang, Xi Chen, Hongjing Han, Huan Shen, Tomasz Brzozowski
Mediators of Inflammation. 2021; 2021: 1
[Pubmed] | [DOI]
33 Stem Cell-Based Therapy for Asherman Syndrome: Promises and Challenges
Yiyin Gao, Guijie Wu, Ying Xu, Donghai Zhao, Lianwen Zheng
Cell Transplantation. 2021; 30: 0963689721
[Pubmed] | [DOI]
34 Effects of bone marrow mesenchymal stem cells on repair and receptivity of damaged endometrium in rats
Guiling Wang, Chun'e Ren, Junyi Jiang
Journal of Obstetrics and Gynaecology Research. 2021; 47(9): 3223
[Pubmed] | [DOI]
35 Endometrial Perivascular Progenitor Cells and Uterus Regeneration
Shiyuan Li, Lijun Ding
Journal of Personalized Medicine. 2021; 11(6): 477
[Pubmed] | [DOI]
36 Making More Womb: Clinical Perspectives Supporting the Development and Utilization of Mesenchymal Stem Cell Therapy for Endometrial Regeneration and Infertility
Michael Strug, Lusine Aghajanova
Journal of Personalized Medicine. 2021; 11(12): 1364
[Pubmed] | [DOI]
37 Application of Stem Cell Therapy for Infertility
Sarama Saha, Partha Roy, Cynthia Corbitt, Sham S. Kakar
Cells. 2021; 10(7): 1613
[Pubmed] | [DOI]
38 The Role of Stem Cells and Their Derived Extracellular Vesicles in Restoring Female and Male Fertility
Ahmad Yar Qamar, Tariq Hussain, Muhammad Kamran Rafique, Seonggyu Bang, Bereket Molla Tanga, Gyeonghwan Seong, Xun Fang, Islam M. Saadeldin, Jongki Cho
Cells. 2021; 10(9): 2460
[Pubmed] | [DOI]
39 Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility
Sahar Esfandyari, Rishi Man Chugh, Hang-soo Park, Elie Hobeika, Mara Ulin, Ayman Al-Hendy
Cells. 2020; 9(10): 2253
[Pubmed] | [DOI]
40 Mini-Review of the New Therapeutic Possibilities in Asherman Syndrome—Where Are We after One Hundred and Twenty-Six Years?
Bogdan Doroftei, Ana-Maria Dabuleanu, Ovidiu-Dumitru Ilie, Radu Maftei, Emil Anton, Gabriela Simionescu, Theodor Matei, Theodora Armeanu
Diagnostics. 2020; 10(9): 706
[Pubmed] | [DOI]
41 In situ repair abilities of human umbilical cord–derived mesenchymal stem cells and autocrosslinked hyaluronic acid gel complex in rhesus monkeys with intrauterine adhesion
Lingjuan Wang, Chuanhu Yu, Tianli Chang, Mengdi Zhang, Su Song, Chengliang Xiong, Pin Su, Wenpei Xiang
Science Advances. 2020; 6(21)
[Pubmed] | [DOI]
42 Exosomes Derived from Umbilical Cord Mesenchymal Stem Cells Alleviate Mifepristone-Induced Human Endometrial Stromal Cell Injury
Jianye Wang, Ruomeng Hu, Qiong Xing, Xinghao Feng, Xiaohua Jiang, Yuping Xu, Zhaolian Wei
Stem Cells International. 2020; 2020: 1
[Pubmed] | [DOI]
43 Clinical Efficacy and Safety of Stem Cell-Based Therapy in Treating Asherman Syndrome: A System Review and Meta-Analysis
Yiming Zhao, Qifan Luo, Xiao Zhang, Yafei Qin, Jingpeng Hao, Dejun Kong, Hongda Wang, Guangming Li, Xiangying Gu, Hao Wang, Mahmood S. Choudhery
Stem Cells International. 2020; 2020: 1
[Pubmed] | [DOI]
44 Preventive Effects of Intrauterine Injection of Bone Marrow-Derived Mesenchymal Stromal Cell-Conditioned Media on Uterine Fibrosis Immediately after Endometrial Curettage in Rabbit
Sanaz Bazoobandi, Nader Tanideh, Farhad Rahmanifar, Shahrokh Zare, Omid Koohi-Hosseinabadi, Iman Razeghian-Jahromi, Mehdi Dianatpour, Masoumeh Ahmadi, Arezoo Khoradmehr, Iraj Nabipour, Zahra Khodabandeh, Amin Tamadon, Patricia Murray
Stem Cells International. 2020; 2020: 1
[Pubmed] | [DOI]
45 Transforming growth factor-ß1 in intrauterine adhesion
Ayitila Abudukeyoumu, Ming-Qing Li, Feng Xie
American Journal of Reproductive Immunology. 2020; 84(2)
[Pubmed] | [DOI]
46 Intrauterine transplantation of autologous menstrual blood stem cells increases endometrial thickness and pregnancy potential in patients with refractory intrauterine adhesion
Hailan Ma, Mengting Liu, Yufeng Li, Wei Wang, Keqin Yang, Lanying Lu, Mei He, Taoran Deng, Meiling Li, Dongcheng Wu
Journal of Obstetrics and Gynaecology Research. 2020; 46(11): 2347
[Pubmed] | [DOI]
47 Should we consider alternative therapies to operative hysteroscopy for the treatment of Asherman syndrome?
Xavier Santamaria, James H. Liu, Aghajanova Lusine, Keith Isaacson, Peter Movilla, Hervé Fernandez, Perrine Capmas, Jacques Donnez, Carlos Simón
Fertility and Sterility. 2020; 113(3): 511
[Pubmed] | [DOI]
48 Therapeutic Effect of Human Amniotic Epithelial Cells in Rat Models of Intrauterine Adhesions
Xuechai Bai, Jia Liu, Weixin Yuan, Yang Liu, Wei Li, Siyu Cao, Luyang Yu, Liang Wang
Cell Transplantation. 2020; 29: 0963689720
[Pubmed] | [DOI]
49 Possibilities of application of regenerative technologies in gynecology
Julia V. Denisova, Ekaterina V. Mandra, Aleksey V. Lyundup, Yana Y. Sulina, Leonid S. Aleksandrov, ?nton ?. Ischenko, ?natoliy I. Ischenko, Valery V. Beregovykh
Annals of the Russian academy of medical sciences. 2020; 75(1): 4
[Pubmed] | [DOI]
50 An update on stem cell therapy for Asherman syndrome
Ariel Benor, Steven Gay, Alan DeCherney
Journal of Assisted Reproduction and Genetics. 2020; 37(7): 1511
[Pubmed] | [DOI]
51 Effect of Autologous Adipose-Derived Stromal Vascular Fraction Transplantation on Endometrial Regeneration in Patients of Asherman’s Syndrome: a Pilot Study
Se Yun Lee, Ji Eun Shin, Hwang Kwon, Dong Hee Choi, Ji Hyang Kim
Reproductive Sciences. 2020; 27(2): 561
[Pubmed] | [DOI]
52 Evaluation and treatment of infertile women with Asherman syndrome: an updated review focusing on the role of hysteroscopy
Federica Di Guardo, Luigi Della Corte, George Angelos Vilos, Jose Carugno, Péter Török, Pierluigi Giampaolino, Rahul Manchanda, Salvatore Giovanni Vitale
Reproductive BioMedicine Online. 2020; 41(1): 55
[Pubmed] | [DOI]
53 Sonic Hedgehog, a Novel Endogenous Damage Signal, Activates Multiple Beneficial Functions of Human Endometrial Stem Cells
Se-Ra Park, Soo-Rim Kim, Chan Hum Park, Soyi Lim, Seung Yeon Ha, In-Sun Hong, Hwa-Yong Lee
Molecular Therapy. 2020; 28(2): 452
[Pubmed] | [DOI]
54 Perivascular Stem Cell-Derived Cyclophilin A Improves Uterine Environment with Asherman’s Syndrome via HIF1a-Dependent Angiogenesis
Mira Park, Seok-Ho Hong, So Hee Park, Yeon Sun Kim, Seung Chel Yang, Hye-Ryun Kim, Songmi Noh, Sunghun Na, Hyung Keun Lee, Hyunjung J. Lim, Sang Woo Lyu, Haengseok Song
Molecular Therapy. 2020; 28(8): 1818
[Pubmed] | [DOI]
55 Tryptophanyl-tRNA Synthetase, a Novel Damage-Induced Cytokine, Significantly Increases the Therapeutic Effects of Endometrial Stem Cells
Se-Ra Park, Soo-Rim Kim, Jae-Been Im, Soyi Lim, In-Sun Hong
Molecular Therapy. 2020; 28(11): 2458
[Pubmed] | [DOI]
56 Endometrial autotransplantation in rabbits: Potential for fertility restoration in severe Asherman’s syndrome
Benjamin P. Jones, Saaliha Vali, Srdjan Saso, Ximo Garcia-Dominguez, Maxine Chan, Meen-Yau Thum, Sadaf Ghaem-Maghami, Baljeet Kaur, Luís García-Valero, Linda Petrucci, Joseph Yazbek, Jose S. Vicente, Isabel Quiroga, Francisco Marco-Jiménez, J. Richard Smith
European Journal of Obstetrics & Gynecology and Reproductive Biology. 2020; 248: 14
[Pubmed] | [DOI]
57 Application of autologous adipose-derived stem cells for thin endometrium treatment in patients with failed ART programs
I Sudoma, L Pylyp, Y Kremenska, Y* Goncharova
Journal of Stem Cell Therapy and Transplantation. 2019; 3(1): 001
[Pubmed] | [DOI]
58 Bone Marrow Mesenchymal Stem Cells (BMSCs) Restore Functional Endometrium in the Rat Model for Severe Asherman Syndrome
Lufen Gao, Zhongwei Huang, Haiyingjie Lin, Yuke Tian, Ping Li, Shaoqiang Lin
Reproductive Sciences. 2019; 26(3): 436
[Pubmed] | [DOI]
59 Current status of uterine regenerative medicine for absolute uterine factor infertility (Review)
Yusuke Matoba, Iori Kisu, Asako Sera, Megumi Yanokura, Kouji Banno, Daisuke Aoki
Biomedical Reports. 2019;
[Pubmed] | [DOI]
60 Regeneration of the Fallopian Tube Mucosa Using Bone Marrow Mesenchymal Stem Cell Transplantation After Induced Chemical Injury in a Rat Model
Shaima M. Almasry, Amr K. Elfayomy, Mohamed H. El-Sherbiny
Reproductive Sciences. 2018; 25(5): 773
[Pubmed] | [DOI]
61 Stem cell therapy in Asherman syndrome and thin endometrium: Stem cell- based therapy
Ramyar Azizi, Leili Aghebati-Maleki, Mohammad Nouri, Faroogh Marofi, Sohrab Negargar, Mehdi Yousefi
Biomedicine & Pharmacotherapy. 2018; 102: 333
[Pubmed] | [DOI]
62 An Innovative New Treatment for Asherman Syndrome with an Intrauterine Amniograft: A Case Series
GG Collins
Global Journal of Fertility and Research. 2016; 1(1): 016
[Pubmed] | [DOI]
63 Very small embryonic-like stem cells are the elusive mouse endometrial stem cells- a pilot study
Pranesh Gunjal, Deepa Bhartiya, Siddhanath Metkari, Dhananjay Manjramkar, Hiren Patel
Journal of Ovarian Research. 2015; 8(1)
[Pubmed] | [DOI]
64 Uterine Infusion With Bone Marrow Mesenchymal Stem Cells Improves Endometrium Thickness in a Rat Model of Thin Endometrium
Jing Zhao, Qiong Zhang, Yonggang Wang, Yanping Li
Reproductive Sciences. 2015; 22(2): 181
[Pubmed] | [DOI]
65 Human CD133+ bone marrow-derived stem cells promote endometrial proliferation in a murine model of Asherman syndrome
Irene Cervelló, Claudia Gil-Sanchis, Xavier Santamaría, Sergio Cabanillas, Ana Díaz, Amparo Faus, Antonio Pellicer, Carlos Simón
Fertility and Sterility. 2015; 104(6): 1552
[Pubmed] | [DOI]
66 Live birth after embryo transfer in an unresponsive thin endometrium
Fábio Cruz,José Bellver
Gynecological Endocrinology. 2014; : 1
[Pubmed] | [DOI]
67 Treating patients with “thin” endometrium – an ongoing challenge
Oshrit Lebovitz,Raoul Orvieto
Gynecological Endocrinology. 2014; : 1
[Pubmed] | [DOI]
68 The management of Asherman syndrome: a review of literature
Alessandro Conforti,Carlo Alviggi,Antonio Mollo,Giuseppe De Placido,Adam Magos
Reproductive Biology and Endocrinology. 2013; 11(1): 118
[Pubmed] | [DOI]
69 Regenerating endometrium from stem/progenitor cells
James A. Deane,Rosa C. Gualano,Caroline E. Gargett
Current Opinion in Obstetrics and Gynecology. 2013; 25(3): 193
[Pubmed] | [DOI]
70 Menstrual blood stem cells as a potential source for cell therapy
S. V. Anisimov,V. I. Zemelko,T. M. Grinchuk,N. N. Nikolsky
Cell and Tissue Biology. 2013; 7(3): 201
[Pubmed] | [DOI]
71 Rat bone marrow mesenchymal stem cells improve regeneration of thin endometrium in rat
Zhao Jing,Zhang Qiong,Wang Yonggang,Li Yanping
Fertility and Sterility. 2013;
[Pubmed] | [DOI]
72 Creation of a female rabbit model for intrauterine adhesions using mechanical and infectious injury
Fang Liu,Zhi-Jun Zhu,Peng Li,Yuan-Li He
Journal of Surgical Research. 2013; 183(1): 296
[Pubmed] | [DOI]
73 Creation of a female rabbit model for intrauterine adhesions using mechanical and infectious injury
Liu, F. and Zhu, Z.-J. and Li, P. and He, Y.-L.
Journal of Surgical Research. 2013; 183(1): 296-303
74 Regenerating endometrium from stem/progenitor cells: Is it abnormal in endometriosis, Ashermanæs syndrome and infertility?
Deane, J.A. and Gualano, R.C. and Gargett, C.E.
Current Opinion in Obstetrics and Gynecology. 2013; 25(3): 193-200
75 Menstrual blood stem cells as a potential source for cell therapy
Anisimov, S.V. and Zemelko, V.I. and Grinchuk, T.M. and Nikolsky, N.N.
Cell and Tissue Biology. 2013; 7(3): 201-206
76 Atypical expression of COX-2, StAR, CYP19A1 and apoptotic regulators in CD90 positive endometrial stromal cells from women with endometriosis
Kadalmani, B. and Taylor, H.S. and Krikun, G. and Palanivel, K.
Journal of Endometriosis. 2013; 5(2): 77-85
77 Endocrine aspects of endometrial stem cell function in reproductive-age women
Götte, M. and Kiesel, L.
Journal fur Reproduktionsmedizin und Endokrinologie. 2013; 10(SPL. 1): 120-125
78 Somatic stem cells in the human endometrium
Cervelló, I. and Mas, A. and Gil-Sanchis, C. and Simón, C.
Seminars in Reproductive Medicine. 2013; 31(1): 69-76
79 Atypical Expression of COX-2, StAR, CYP19A1 and Apoptotic Regulators in CD90 Positive Endometrial Stromal Cells from Women with Endometriosis
Balamuthu Kadalmani, Hugh S. Taylor, Graciela Krikun, Kavitha Palanivel
Journal of Endometriosis and Pelvic Pain Disorders. 2013; 5(2): 77
[Pubmed] | [DOI]
80 Endometrial regeneration and endometrial stem/progenitor cells
Gargett, C.E. and Nguyen, H.P.T. and Ye, L.
Reviews in Endocrine and Metabolic Disorders. 2012; 13(4): 235-251
81 Endometrial reconstruction from stem cells
Gargett, C.E. and Ye, L.
Fertility and Sterility. 2012; 98(1): 11-20
82 Endometrial regeneration and endometrial stem/progenitor cells
Caroline E. Gargett,Hong P. T. Nguyen,Louie Ye
Reviews in Endocrine and Metabolic Disorders. 2012; 13(4): 235
[Pubmed] | [DOI]
83 Endometrial reconstruction from stem cells
Caroline E. Gargett,Louie Ye
Fertility and Sterility. 2012; 98(1): 11
[Pubmed] | [DOI]
84 Generating receptive endometrium in Ashermans syndrome
Gargett, C., Healy, D.
Journal of Human Reproductive Sciences. 2011; 4(1): 49-52


Print this article  Email this article


    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Article in PDF (1,708 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

    Case Report
    Article Figures

 Article Access Statistics
    PDF Downloaded667    
    Comments [Add]    
    Cited by others 84    

Recommend this journal